retatrutide telehealth Peptide Therapy Retatrutide Starting Dose: 7 Factors

At six months, patients treated with tirzepatide experienced greater average weight loss than those treated with semaglutide (-11.15% vs -8.83%), with more patients reaching clinically meaningful weight-loss thresholds

Of the included papers, 16 were randomised control trials (RCT), five were single arm interventional studies, one was a non-randomised comparative interventional study and one was a phase IV clinical trial

That selectivity is exactly why this particular secretagogue, stacked with CJC-1295, has become the default growth hormone peptide protocol in modern medical clinics

We will explore this more in a future blog, but this blog focusses on fat burning

The even better news is that the treatment can be highly effective